Treatment of asbestos

Details Treatment of asbestos Treatment of asbestos

1983-02-17

1984-10-02

Doll, John

Chemistry of inorganic compounds

Silicon or compound thereof

Oxygen containing

423326, C01B 3324

Patent

active

044747420

ABSTRACT:
Toxicity of asbestos is reduced by treating it with non-mutagenic non-toxic hydroxamic acid iron-chelating agents.

REFERENCES:
patent: 2394040 (1946-02-01), Caillman
patent: 3535150 (1970-10-01), Lipsett
patent: 3967043 (1976-06-01), Otouma et al.
patent: 4137367 (1979-01-01), Sample, Jr. et al.
patent: 4168346 (1979-09-01), Pezzoli
patent: 4171405 (1979-10-01), Pezzoli
patent: 4234377 (1980-11-01), Pezzoli
patent: 4303553 (1981-12-01), Aoki et al.
patent: 4309477 (1982-01-01), Pezzoli
patent: 4328197 (1982-05-01), Flowers
patent: 4401636 (1983-08-01), Flowers
Paul G. Stecher, et al., The Merck Index Eight Edition, Merck & Co., Inc., Rahway, N.J., 1968, p. 324.
Mossman, B. J., Landesman, J. M., "Importance of Oxygen Free Radicals in Asbestos-Induced Injury to Airway Epithelial Cells," Chest May 1983, 83(55uppl), pp. 505-515, ISSN 0012-3692, Contract/Grant No. 00888.
"Biological Autooxidation, I Decontrolled Iron: An Ultimate Carcinogen and Toxicant: An Hypothesis," Kohn S. H., Medical Hypotheses, Sep.Oct. 1978, 4(5), pp. 445-471, ISSN-0306-9877.

Affiliated with

Also associated with

Rating

Treatment of asbestos does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of asbestos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of asbestos will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-526296